Pre-Meeting Workshop: Creative and Collaborative - Pharmacists on the Front-line of Medication Assisted Treatment for Opioid Use Disorder

Sarah Melton, PharmD, BCPP, BCACP, FASCP
Pre-Meeting Workshop Chair

Workshop Speakers

Christopher M. Jones, PharmD, MPH
Director of the National Mental Health and Substance Use Policy Laboratory
US Department of Health and Human Services 

No Relevant Financial Relationships to Disclose

Christopher M. Jones currently serves as the Director of the National Mental Health and Substance Use Policy Laboratory at the Substance Abuse and Mental Health Services Administration (SAMHSA). The Policy Lab, created in the 21st Century Cures Act, is charged with identifying, coordinating, and facilitating the implementation of policy changes likely to have a significant effect on mental health, mental illness, recovery supports, and the prevention and treatment of substance use disorders, and working to advance innovation and the dissemination and adoption of evidence-based practices and programs related to mental health and substance abuse. Prior to joining SAMHSA, Dr. Jones served as Acting Associate Deputy Assistant Secretary for Science and Data Policy and Director of the Division of Science Policy in the Office of the Assistant Secretary for Planning and Evaluation (ASPE) at the U.S. Department of Health and Human Services. The Office of Science and Data Policy is the HHS focal point for policy research, analysis, evaluation, and coordination of public health, science, and data policy activities, and provides authoritative advice and analytical support to HHS leadership on public health, science, and data policy issues and initiatives. He has also served as senior advisor in the Office of the Commissioner at the U.S. Food and Drug Administration (FDA) and led the Centers for Disease Control and Prevention’s (CDC) drug abuse and overdose activities where he focused on strategic policy development and implementation, engaging national and state partners, and conducting research to improve policy and clinical practice. During his career, Dr. Jones has served as Senior Public Health Advisor to the White House Office of National Drug Control Policy, led the FDA’s Drug Safety and Risk Communication team, and served on the Science Team in the CDC’s Strategic National Stockpile.  He received his Bachelor of Science degree from Reinhart College, his Doctor of Pharmacy degree from Mercer University, his Master of Public Health degree from New York Medical College, and is currently completing his Doctorate of Public Health in Heath Policy at The George Washington University Milken Institute School of Public Health. Dr. Jones has authored more than 50 peer-reviewed publications on the topic of drug abuse and overdose.

Ray Love, PharmD, BCPP, FASHP
Professor of Pharmacy
Vice Chair for the Department of Pharmacy Practice and Science
Director Mental Health Program
University of Maryland

Troy Moore, PharmD, MS, BCPP
Clinical Pharmacy Specialist/Assistant Professor
STVHCS/University of Texas HSC San Antonio

No Relevant Financial Relationships to Disclose

Troy A. Moore received his PharmD from the University of New Mexico College of Pharmacy in 2003.  He subsequently attended the University of Texas at Austin College of Pharmacy, receiving his Master of Science in Pharmacy in 2005 while completing a 2-year Psychiatric Pharmacy Residency at the San Antonio State Hospital and the South Texas Veterans Health Care System (STVHCS). He joined the University of Texas Health Science Center at San Antonio Department of Psychiatry, Division of Schizophrenia and Related Disorders in 2005 and became Assistant Professor in 2007. He joined the STVHCS as Clinical Pharmacy Specialist in Psychiatry in 2010 where he serves the Substance Abuse and Domiciliary Programs. He is the author of numerous publications, including the Texas Medication Algorithm Project antipsychotic algorithm for schizophrenia: 2006 update. He is a reviewer for multiple psychiatric and pharmacy journals. He is currently the Director of the ASHP accredited PGY-2 Psychiatric Pharmacy Residency at STVHCS, serves as the Chair of the STVHCS Pharmacy Professional Standards Board, and serves as one of the handling editors for the Mental Health Clinician. Dr. Moore previously served as Co-Director of the Advanced Fellowship in Addiction Treatment at STVHCS, Chair of the Board of Pharmacy Specialties Specialty Council on Psychiatric Pharmacy, and the Member-at-Large on the Board of Director for the College of Psychiatric and Neurologic.

Bethany DiPaula, PharmD, BCPP
Associate Professor, University of Maryland
Director of Pharmacy, Springfield Hospital Center

No Relevant Financial Relationships to Disclose

Gayle Callahan, PharmD, BCPP
Substance Use Disorder/Mental Health Consultant Pharmacist
Operation PAR/Diversified Consultant Pharmacists

No Relevant Financial Relationships to Disclose

Gayle Callahan, CPH,Pharm.D, BCPP is the Director of Pharmacy Services for Operation PAR, Pinellas Park FL where she has provided consultant pharmacy services for the past 14 years. She received her B.S. in Chemistry and Pharmacy from the State University of New York at Buffalo and her doctor of Pharmacy from the University of Florida, and is a Board Certified Psychiatric Pharmacist. She has been very active in the substance use disorder field for many years and has presented on medication-assisted treatment on numerous occasions on both the state and national level. She has acted in a faculty capacity for Nova Southeastern University for over 10 years. In her role as Director of Pharmacy at Operation PAR she is currently very involved with naloxone distribution with over 2500 doses dispensed to date. She is collaborating in a HRSA grant between Operation PAR and local FQHC clinic providing integration of primary care, case management and SUD services for homeless individuals, as well as incorporating NaltrexoneXR into MAT in all treatment settings.